Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Large study aims to uncover hidden causes of bile duct cancer

NCT ID NCT05179486

First seen Oct 31, 2025 · Last updated Jun 23, 2026 · Updated 31 times

Summary

This study is collecting tissue and blood samples, along with questionnaires, from 1,500 people with biliary tree cancers and healthy volunteers. Researchers hope to identify risk factors and genetic changes that influence how these cancers develop and respond to treatment. The goal is to build better models for predicting outcomes and personalizing care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHOLANGIOCARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • M D Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help doctors better understand what causes biliary tree cancers and why some patients respond differently to treatments.

What could go wrong

This is an observational study, not a treatment trial. It may not lead directly to new therapies, and results may take years to influence patient care.

Conditions

The condition(s) this trial relates to.

cholangiocarcinoma digestive system neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.